Diabetic Neuropathies: all 629 studies
Page 7 of 7. Open to participants first (92), then studies with results posted, then the rest; newest registration first within each.
- An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)CompletedNCT00194909Phase 4
- The Effect of Ruboxistaurin on Small Fiber FunctionCompletedNCT00190970Phase 2
- Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral NeuropathyCompletedNCT00159731Phase 4
- Pregabalin in the Treatment of Pain Due to Diabetic Peripheral NeuropathyCompletedNCT00159679Phase 4
- A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)CompletedNCT00156078Phase 4
- To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.CompletedNCT00150423Phase 3
- Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT00143156Phase 3
- Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.CompletedNCT00141401Phase 3
- Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic NeuropathyCompletedNCT00135109Phase 3
- The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral NeuropathyStatus unknownNCT00134524Phase 3
- Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral NeuropathyStatus unknownNCT00123136Phase 4
- Anodyne Therapy in Diabetic Sensory NeuropathyCompletedNCT00120341Phase 4
- Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic NeuropathyCompletedNCT00113620Phase 3
- Clinical Trial of SB-509-0401 in Subjects With Diabetic NeuropathyCompletedNCT00110500Phase 1
- Dermal Thermometry and Self-Care of High Risk Diabetic PatientsCompletedNCT00105755Not applicable
- Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor PolyneuropathyCompletedNCT00101426Phase 3
- An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainTerminatedNCT00089557Phase 2
- Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainCompletedNCT00082316Phase 2
- Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyTerminatedNCT00073034Phase 2
- A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
- VEGF Gene Transfer for Diabetic NeuropathyCompletedNCT00056290Phase 1/2
- Treatment of Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044421Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044408Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3
- Lidorestat (IDD 676) for the Treatment of Diabetic NeuropathyStatus unknownNCT00043797Phase 2
- A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEXTerminatedNCT00034788Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic NeuropathyCompletedNCT00004647Phase 3
- Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic NeuropathyTerminatedNCT00004407Not applicable
- Dextromethorphan Versus Placebo for Neuropathic PainCompletedNCT00001344Phase 2